Drug Type Small molecule drug |
Synonyms EGFR-C797S Inhibitor(PearlRiver Bio) |
Target |
Action inhibitors |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Non-Small Cell Lung Cancer | Preclinical | United States | 09 Sep 2021 | |
| Non-Small Cell Lung Cancer | Preclinical | Germany | 09 Sep 2021 |





